home / openregs / documents

documents: FDA-2021-D-0776-0013

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-D-0776-0013 FDA FDA-2021-D-0776 Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial; Guidance for Industry; Availability Notice Guidance 2022-11-07T05:00:00Z 2022 11 2022-11-07T05:00:00Z   2022-11-07T13:31:59Z 2022-24112 0 0 0900006485492c29

Links from other tables

  • 1 row from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 99.857ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API